Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blasts

The prognostic impact of monocytosis has not yet been determined in patients with myelodysplastic syndromes (MDS). We examined absolute monocyte counts in the peripheral blood at the time of diagnosis in 1949 patients with a bone marrow blast count < 5%, a condition we call MDS < EB1 (MDS with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasprzak, A., Assadi, C., Nachtkamp, K., Rudelius, M., Haas, R., Giagounidis, A., Götze, K., Gattermann, N., Germing, U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807467/
https://www.ncbi.nlm.nih.gov/pubmed/36409328
http://dx.doi.org/10.1007/s00277-022-05043-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807467/
https://www.ncbi.nlm.nih.gov/pubmed/36409328
http://dx.doi.org/10.1007/s00277-022-05043-y

Ejemplares similares